News

Retatrutide is a novel triple receptor agonist that targets GIP, GLP-1, and glucagon receptors simultaneously. It regulates blood sugar, slows down...

Driven by the tide of globalisation, commercial cooperation has long transcended geographical boundaries. Enterprises from different nations collab...

SLU-PP-332 capsule is an innovative drug with a core component of a general estrogen receptor-related receptor (ERR) agonist. It activates the thre...

NA-931 capsules10mg contain 10mg per capsule. U.S. customer Kenny has ordered 500 capsules. NA-931 is a peptide substance with unique biological ac...

One injection per week! Novo Nordisk's new compound preparation Kyinsu has been approved by the European Union On November 26, 2025, Novo Nordi...

Novo Nordisk Amycretin diabetes Phase II Clinical Data Release On November 25, 2025, Novo Nordisk announced that the GLP-1/Amylin double target ago...

GLP-1 Injections 1.General Specification(in stock) (1)API(Pure powder) (2)Tablet (3)Capsule (4)Injection (5)Liquid Drops 2.Customization: We will n...

Lyophilized Semaglutide CAS 910463-68-2 Product Code: BM-2-4-043 English Name: Semaglutide CAS No.: 910463-68-2 Molecular formula: C187H291N45O59 M...

Fosun Pharma GLP-1 drug and Huiruida have reached an exclusive cooperation and licensing agreement On December 9, 2025, Fosun Pharma (600196. SH; 0...

Shuodi Biotech announces phase 2b clinical data on weight loss of small molecule GLP-1 On December 8, 2025, Shuodi Biotechnology announced that the...

Shiyao Group's GLP-1/GIP receptor dual directional agonist peptide injection (SYH2069 injection) has been approved for clinical use in the Unit...

Franky, a long-term customer from Indonesia, has seen good results using our products. Therefore, based on his requirements, he has repurchased new...